Hyperion Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Hyperion Therapeutics, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RAVICTI, BUPHENYL, and HYPERION THERAPEUTICS. The owner is based in South San Francisco, CA.
Suite 200
601 Gateway Blvd.
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Hyperion Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Hyperion Therapeutics, Inc. have?
Hyperion Therapeutics, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned.
What trademark classes does Hyperion Therapeutics, Inc. file in?
Hyperion Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hyperion Therapeutics, Inc.'s most well-known trademarks?
Hyperion Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as RAVICTI, BUPHENYL, and HYPERION THERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.
What is Hyperion Therapeutics, Inc.'s trademark registration success rate?
Hyperion Therapeutics, Inc. has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.